Related Experiment Video
Updated: Nov 21, 2025
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo
Fanpeng Zhao1, Quillan Austria1, Wenzhang Wang1
1Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract:
Mitochondrial dysfunction represents a critical event in the pathogenesis of Parkinson's disease (PD). Increasing evidence demonstrates that disturbed mitochondrial dynamics and quality control play an important role in mitochondrial dysfunction in PD. Our previous study demonstrated that MPP+ induces mitochondrial fragmentation in vitro. In this study, we aimed to assess whether blocking MPTP-induced mitochondrial fragmentation by overexpressing Mfn2 affords neuroprotection in vivo. We found that the significant loss of dopaminergic neurons in the substantia nigra (SN) induced by MPTP treatment, as seen in wild-type littermate control mice, was almost completely blocked in mice overexpressing Mfn2 (hMfn2 mice). The dramatic reduction in dopamine neuronal fibers and dopamine levels in the striatum caused by MPTP administration was also partially inhibited in hMfn2 mice. MPTP-induced oxidative stress and inflammatory response in the SN and striatum were significantly alleviated in hMfn2 mice. The impairment of motor function caused by MPTP was also blocked in hMfn2 mice. Overall, our work demonstrates that restoration of mitochondrial dynamics by Mfn2 overexpression protects against neuronal toxicity in an MPTP-based PD mouse model, which supports the modulation of mitochondrial dynamics as a potential therapeutic target for PD treatment.
Insights
Overexpressing Mfn2 blocked mitochondrial fragmentation and protected against neuronal loss in a Parkinson
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Neurodegenerative Diseases
Background:
- Mitochondrial dysfunction is central to Parkinson's disease (PD) pathogenesis.
- Disrupted mitochondrial dynamics and quality control contribute to PD-related mitochondrial dysfunction.
- Previous research showed MPP+ causes in vitro mitochondrial fragmentation.
Purpose of the Study:
- To investigate if inhibiting MPTP-induced mitochondrial fragmentation via Mfn2 overexpression provides in vivo neuroprotection.
- To evaluate Mfn2's therapeutic potential in a Parkinson's disease model.
Main Methods:
- Utilized a mouse model overexpressing Mfn2 (hMfn2 mice).
- Administered MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to induce Parkinson's-like pathology.
- Assessed dopaminergic neuron survival in the substantia nigra (SN), dopamine levels, oxidative stress, inflammation, and motor function.
Main Results:
- Mfn2 overexpression almost completely blocked MPTP-induced dopaminergic neuron loss in the SN.
- MPTP-induced reduction in striatal dopamine fibers and levels was partially inhibited in hMfn2 mice.
- Oxidative stress, inflammation, and motor function impairment were significantly alleviated in hMfn2 mice.
Conclusions:
- Restoring mitochondrial dynamics through Mfn2 overexpression confers significant neuroprotection in an MPTP-based PD model.
- Modulating mitochondrial dynamics represents a promising therapeutic strategy for Parkinson's disease.
More Related Videos
05:38Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
